Publications
Print PDF
Genentech and Amgen Cease Fire on Biosimilar Litigation
July 9, 2020
Tony Hagen
The Center for Biosimilars

Axinn partner Ted Mathias was quoted in The Center for Biosimilars article, "Genentech and Amgen Cease Fire on Biosimilar Litigation."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.